SCHEMBL8228071

SCHEMBL8228071

Cc1cnccc1C(=O)Nc1ccc(-c2cc(-c3nccs3)oc2C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2C19 P33261 2/20 0.41
ALDH1A1 P00352 2/20 0.41
KMT2A Q03164 2/20 0.41
MAPK1 P28482 1/20 0.41
MCL1 Q07820 2/20 0.40
STIM1 Q13586 1/20 0.39
ORAI1 Q96D31 1/20 0.39
NAMPT P43490 2/20 0.38
F2 P00734 1/20 0.38
F10 P00742 1/20 0.38
PLG P00747 1/20 0.38
F7 P08709 1/20 0.38
F3 P13726 1/20 0.38
PORCN Q9H237 1/20 0.37
TYK2 P29597 1/20 0.37
KIF18A Q8NI77 1/20 0.37
MAPT P10636 3/20 0.37
IKBKE Q14164 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5029494 0.91 STIM1 (0.51) ADORA2ACYP3A4CYP2C19ALDH1A1KMT2A
SCHEMBL8233603 0.84 IL2 (0.38) ALDH1A1KMT2AMAPK1STIM1ORAI1
SCHEMBL4724893 0.84 ABL1 (0.44) ADORA2ACYP3A4CYP2C19MCL1STIM1
SCHEMBL5027387 0.83 IL2 (0.40) ALDH1A1KMT2AMAPK1STIM1ORAI1
SCHEMBL4768209 0.82 F2 (0.42) ADORA2ACYP3A4CYP2C19MCL1STIM1
SCHEMBL5033790 0.80 IL2 (0.48) ALDH1A1KMT2ASTIM1ORAI1TYK2
SCHEMBL5030903 0.79 ADORA2A (0.43) ADORA2ACYP3A4CYP2C19ALDH1A1KMT2A
SCHEMBL8236360 0.79 LMNA (0.48) ALDH1A1KMT2AMAPK1ORAI1MEN1
SCHEMBL2813632 0.77 MCL1 (0.44) ADORA2ACYP3A4CYP2C19KMT2AMCL1
SCHEMBL5030918 0.77 LMNA (0.48) ALDH1A1KMT2ASTIM1ORAI1TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007087429-A2 PHENYL AND PYRIDYL COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2007-08-02 WO disclosed